PubRank

Joseph G Jurcic

Author PubWeight™ 18.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood 2011 2.59
2 Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. J Clin Oncol 2006 1.98
3 Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death. Leuk Res 2013 1.70
4 The promise of targeted {alpha}-particle therapy. J Nucl Med 2005 1.43
5 Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. J Clin Oncol 2008 1.28
6 Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia. Clin Cancer Res 2010 1.17
7 Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer 2003 1.02
8 Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia. J Clin Oncol 2003 0.99
9 Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial. Leuk Lymphoma 2009 0.94
10 Randomized phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia. Haematologica 2012 0.87
11 Radioimmunotherapy for acute leukemia. Cancer Control 2002 0.86
12 Emerging new approaches for the treatment of acute promyelocytic leukemia. Ther Adv Hematol 2011 0.78
13 Induction and postremission strategies in acute myeloid leukemia: state of the art and future directions. Hematol Oncol Clin North Am 2011 0.78
14 A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer 2002 0.77
15 Antibody-based treatment of acute myeloid leukaemia. Expert Opin Biol Ther 2004 0.77
16 Antibody-drug conjugates in acute myeloid leukemia. Nat Clin Pract Oncol 2006 0.75
17 Radioimmunotherapy of leukemia. Adv Pharmacol 2004 0.75
18 Antibody therapy in acute myeloid leukemia: current status and future directions. Clin Lymphoma 2002 0.75